Peroxisome Proliferator Activator Receptor γ Coactivator-1 Expression Is Reduced in Obesity
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Peroxisome proliferator activator receptor-gamma coactivator 1 (PGC-1) is a major candidate gene for diabetes-related metabolic phenotypes, contributing to decreased expression of nuclear-encoded mitochondrial genes in muscle and adipose tissue. We have demonstrated that muscle expression of PGC-1alpha and -beta is reduced in both genetic (Lep(ob)/Lep(ob)) and acquired obesity (high fat diet). In C57BL6 mice, muscle PGC-1alpha expression decreased by 43% (p < 0.02) after 1 week of a high fat diet and persisted more than 11 weeks. In contrast, PGC-1alpha reductions were not sustained in obesity-resistant A/J mice. To identify mediators of obesity-linked reductions in PGC-1, we tested the effects of cellular nutrients in C2C12 myotubes. Although overnight exposure to high insulin, glucose, glucosamine, or amino acids had no effect, saturated fatty acids potently reduced PGC-1alpha and -beta mRNA expression. Palmitate decreased PGC-1alpha and -beta expression by 38% (p = 0.01) and 53% (p = 0.006); stearate similarly decreased expression of PGC-1alpha and -beta by 22% (p = 0.02) and 39% (p = 0.02). These effects were mediated at a transcriptional level, as indicated by an 11-fold reduction of PGC-1alpha promoter activity by palmitate and reversal of effects by histone deacetylase inhibition. Palmitate also (a) reduced expression of tricarboxylic acid cycle and oxidative phosphorylation mitochondrial genes and (b) reduced oxygen consumption. These effects were reversed by overexpression of PGC-1alpha or -beta, indicating PGC-1 dependence. Palmitate effects also required p38 MAPK, as demonstrated by 1) palmitate-induced increase in p38 MAPK phosphorylation, 2) reversal of palmitate effects on PGC-1 and mitochondrial gene expression by p38 MAPK inhibitors, and 3) reversal of palmitate effects by small interfering RNA-mediated decreases in p38alpha MAPK. These data indicate that obesity and saturated fatty acids decrease PGC-1 and mitochondrial gene expression and function via p38 MAPK-dependent transcriptional pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In support of this concept, recent studies have reported that raising serum free fatty acids (FFA) by a high-fat diet in humans (8), or by feeding mice or rats high-fat diets (8–10), results in decreases in skeletal muscle peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) mRNA (8–10) and the mRNA levels of various mitochondrial constituents (8).”
From High-fat diets cause insulin resistance despite an increase in muscle mitochondria (2008) · cites this paper as [9]
In the citing paper
“For example, there is considerable evidence that a high-fat diet can reduce the expression of transcriptional regulators that are necessary for T3 signaling in the liver (73–75).”
From Emerging Therapies in Hypothyroidism (2024) · cites this paper as [73]
In the citing paper
“a p38-dependent reduction in transcript levels of PGC-1α is observed in myotubes treated with the saturated fatty acid palmitate [79]”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [79]
In the citing paper
“PGC-1α levels are reduced in genetic and dietary induced rodent obesity models [79].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [79]
In the citing paper
“PGC-1α levels are dramatically reduced in skeletal muscle in genetic and sustained diet induced mouse models of obesity [79].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [79]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
Self-citationImpaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Puigserver, P., & Spiegelman, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0012 · Cited by 2,076
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
Self-citationAbsence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., et al. (2004) · Nature · doi:10.1038/nature02866 · Cited by 1,677
Cited by
Hirschey, M. D., Shimazu, T., Jing, E., Grueter, C. A., Collins, A. M., Aouizerat, B., Stančáková, A., Goetzman, E., Lam, M. M., Schwer, B., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.07.019 · Cited by 787
“Furthermore, we found a 1.7-fold increase in SIRT3 expression in mice overexpressing adenoviral PGC-1a fed aHFD, compared tomice overexpressing adenoviral GFP (Figure 1F).”
InfluentialTranscriptional Control of Mitochondrial Biogenesis and Function
Hock, M. B., & Kralli, A. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163119 · Cited by 614
“However, activation of p38 in myotubes exposed to palmitate leads to decreased PGC-1α expression, suggesting that p38 can act both positively and negatively, depending on cellular context (150).”
BackgroundThe inflammation highway: metabolism accelerates inflammatory traffic in obesity
Johnson, A. R., Justin Milner, J., & Makowski, L. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01151.x · Cited by 603
“Stress kinases associated with inflammatory activation in adipose include the DAGactivated protein kinase C (PKC) (149–152), mitogen-activated protein kinase (MAPK) pathway members including c-Jun N-terminal kinase (JNK) (153–156), extracellular signal-regulated kinase (157, 158), p38 MAPK (153, 159), as well as inhib…”
BackgroundKennedy, A., Martinez, K., Chuang, C.-C., LaPoint, K., & McIntosh, M. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.098269 · Cited by 560
The role of mitochondria in the pathogenesis of type 2 diabetes
Patti, M.-E., & Corvera, S. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0027 · Cited by 551
“that genetic background (127), age at dietary intervention,”
BackgroundSelf-citationHigh-fat diets cause insulin resistance despite an increase in muscle mitochondria
Hancock, C. R., Han, D.-H., Chen, M., Terada, S., Yasuda, T., Wright, D. C., & Holloszy, J. O. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802057105 · Cited by 538
Mitochondrial dysfunction in obesity
Bournat, J. C., & Brown, C. W. (2010) · Current Opinion in Endocrinology, Diabetes and Obesity · doi:10.1097/med.0b013e32833c3026 · Cited by 470
“PGC-1α is reduced in adipose tissues of obese individuals [44], and in genetically-induced and diet-induced obese mice [45].”
BackgroundThe transcriptional coactivator PGC-1α mediates exercise-induced angiogenesis in skeletal muscle
Chinsomboon, J., Ruas, J., Gupta, R. K., Thom, R., Shoag, J., Rowe, G. C., Sawada, N., Raghuram, S., & Arany, Z. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909131106 · Cited by 379
Role of Mitochondria in Nonalcoholic Fatty Liver Disease
Nassir, F., & Ibdah, J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058713 · Cited by 364
“The suppression of SIRT3 occurs at the transcriptional level and is primarily driven by the HFD-induced suppression of PGC-1α, a major regulator of SIRT3 expression [153].”
BackgroundThe Emerging Genetic Architecture of Type 2 Diabetes
Doria, A., Patti, M.-E., & Kahn, C. R. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.006 · Cited by 305
“…in expression (Ling et al., 2004, 2007, Ronn et al., 2008), other studies have suggested that this expression phenotype may be secondary, at least to some extent, to poor physical fitness, obesity, intramyocellular lipid accumulation, or insulin resistance itself (Crunkhorn et al., 2007).”
BackgroundSelf-citationYuzefovych, L. V., Musiyenko, S. I., Wilson, G. L., & Rachek, L. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054059 · Cited by 303
Paradigms of dynamic control of thyroid hormone signaling
Bianco, A. C., Dumitrescu, A., Gereben, B., Ribeiro, M. O., Fonseca, T. L., Fernandes, G. W., & Bocco, B. M. L. C. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00275 · Cited by 293
Self-citationYuzefovych, L., Wilson, G., & Rachek, L. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00238.2010 · Cited by 280
Mitochondrial (Dys)function in Adipocyte (De)differentiation and Systemic Metabolic Alterations
De Pauw, A., Tejerina, S., Raes, M., Keijer, J., & Arnould, T. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.081155 · Cited by 270
Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus
Christensen, D. P., Dahllöf, M., Lundh, M., Rasmussen, D. N., Nielsen, M. D., Billestrup, N., Grunnet, L. G., & Mandrup-Poulsen, T. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00021 · Cited by 261
Chowanadisai, W., Bauerly, K. A., Tchaparian, E., Wong, A., Cortopassi, G. A., & Rucker, R. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.030130 · Cited by 259
Virgili, F., & Marino, M. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.08.001 · Cited by 250
Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators
Piccinin, E., Villani, G., & Moschetta, A. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0089-3 · Cited by 231
FAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure
Hino, S., Sakamoto, A., Nagaoka, K., Anan, K., Wang, Y., Mimasu, S., Umehara, T., Yokoyama, S., Kosai, K.-I., & Nakao, M. (2012) · Nature Communications · doi:10.1038/ncomms1755 · Cited by 226
Newman, J. C., He, W., & Verdin, E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.404863 · Cited by 207
Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome
Bugger, H., & Dale Abel, E. (2008) · Clinical Science · doi:10.1042/cs20070166 · Cited by 198
Brøns, C., Jacobsen, S., Nilsson, E., Rönn, T., Jensen, C. B., Storgaard, H., Poulsen, P., Groop, L., Ling, C., Astrup, A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2413 · Cited by 192
Sarcopenic obesity and endocrinal adaptation with age
Sakuma, K., & Yamaguchi, A. (2013) · International Journal of Endocrinology · doi:10.1155/2013/204164 · Cited by 189
Hypothalamic PGC-1α Protects Against High-Fat Diet Exposure by Regulating ERα
Morselli, E., Fuente-Martin, E., Finan, B., Kim, M., Frank, A., Garcia-Caceres, C., Navas, C. R., Gordillo, R., Neinast, M., Kalainayakan, S. P., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.025 · Cited by 187
“PGC-1α is reduced in adipose tissue in genetically obese mice (Lepob/Lepob) as well as following HFD exposure (Crunkhorn et al., 2007).”
BackgroundThe Orphan Nuclear Receptor, RORα, Regulates Gene Expression That Controls Lipid Metabolism
Lau, P., Fitzsimmons, R. L., Raichur, S., Wang, S.-C. M., Lechtken, A., & Muscat, G. E. O. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710526200 · Cited by 186
SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism
Hirschey, M. D., Shimazu, T., Huang, J. Y., Schwer, B., & Verdin, E. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010850 · Cited by 180
“Overexpression of exogenous PGC-1a was sufficient to rescue the loss of SIRT3 in HFD-fed mice.”
BackgroundThe application of cell‐based label‐free technology in drug discovery
Xi, B., Yu, N., Wang, X., Xu, X., & Abassi, Y. (2008) · Biotechnology Journal · doi:10.1002/biot.200800020 · Cited by 184
Kim, S.-J., Nian, C., Karunakaran, S., Clee, S. M., Isales, C. M., & McIntosh, C. H. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040156 · Cited by 182
“eNos has been linked to the induction of PGC-1a expression [38–39] and both PGC-1a [40] and Ucp2 [41] are involved in mitochondrial biogenesis, reduction of which may contribute to lowering ROS production.”
BackgroundRecent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass
Goodman, C. A., Mayhew, D. L., & Hornberger, T. A. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.07.013 · Cited by 180
Palomer, X., Álvarez-Guardia, D., Rodríguez-Calvo, R., Coll, T., Laguna, J. C., Davidson, M. M., Chan, T. O., Feldman, A. M., & Vázquez-Carrera, M. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvn327 · Cited by 177
Skeletal muscle “mitochondrial deficiency” does not mediate insulin resistance
Holloszy, J. O. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26717c · Cited by 175
Henagan, T. M., Stefanska, B., Fang, Z., Navard, A. M., Ye, J., Lenard, N. R., & Devarshi, P. P. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13058 · Cited by 171
“HDAC inhibition has also been shown to up-regulate expression of PGC1α (Crunkhorn et al., 2007) and PPARγ (Gao et al., 2006), and HDACs have been shown to repress Mef2 (Black and Olson, 1998; Gao et al., 2009; McGee and Hargreaves, 2010).”
BackgroundInfluentialHuman CYP2E1 is regulated by miR-378
Mohri, T., Nakajima, M., Fukami, T., Takamiya, M., Aoki, Y., & Yokoi, T. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.11.015 · Cited by 167
“It has been reported that the expression of PGC1β is down-regulated in diabetes or obesity, but up-regulated by insulin treatment [23,24].”
BackgroundThyroid hormone-related regulation of gene expression in human fatty liver.
Pihlajamäki, J., Boes, T., Kim, E.-Y., Dearie, F., Kim, B. W., Schroeder, J., Mun, E., Nasser, I., Park, P. J., Bianco, A. C., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0212 · Cited by 164
“We analyzed PPARGC1A further because it is a known coactivator of thyroid hormone receptor (THR) (19), and reductions in PPARGC1Aexpressionhavebeen linkedtoreducedskeletal muscle expression of mitochondrial oxidative metabolism genes in humans with diabetes and obesity (20, 21) and after cellular lipid accumulation (1…”
BackgroundSelf-citationPGC-1α in aging and anti-aging interventions
Anderson, R., & Prolla, T. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.04.005 · Cited by 162
Impaired mitochondrial function in human placenta with increased maternal adiposity
Mele, J., Muralimanoharan, S., Maloyan, A., & Myatt, L. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00025.2014 · Cited by 163
Muscle oxidative capacity during IL-6-dependent cancer cachexia
White, J. P., Baltgalvis, K. A., Puppa, M. J., Sato, S., Baynes, J. W., & Carson, J. A. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00300.2010 · Cited by 161
Maternal Pregestational BMI Is Associated With Methylation of the PPARGC1A Promoter in Newborns
Gemma, C., Sookoian, S., Alvariñas, J., García, S. I., Quintana, L., Kanevsky, D., González, C. D., & Pirola, C. J. (2009) · Obesity · doi:10.1038/oby.2008.605 · Cited by 157
“For instance, obesity and experimental high-fat feeding in healthy humans decrease PPARGC1A gene expression (30,31).”
BackgroundTedesco, L., Valerio, A., Dossena, M., Cardile, A., Ragni, M., Pagano, C., Pagotto, U., Carruba, M. O., Vettor, R., & Nisoli, E. (2010) · Diabetes · doi:10.2337/db09-1881 · Cited by 147
Sutherland, L. N., Capozzi, L. C., Turchinsky, N. J., Bell, R. C., & Wright, D. C. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90408.2008 · Cited by 147
Free Fatty Acids and Skeletal Muscle Insulin Resistance
Rachek, L. I. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00008-9 · Cited by 166
Links between Thyroid Hormone Action, Oxidative Metabolism, and Diabetes Risk?
Crunkhorn, S., & Patti, M.-E. (2008) · Thyroid · doi:10.1089/thy.2007.0249 · Cited by 140
Self-citationAlcaín, F. J., & Villalba, J. M. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770902762893 · Cited by 137
“Recently, it has been demonstrated that muscle expression of PGC-1α and PGC-β is reduced both in mouse model, genetic obese (Lepob/Lepob) and in acquired obesity by feeding with a high-fat diet [70].”
BackgroundLanza, I. R., Blachnio-Zabielska, A., Johnson, M. L., Schimke, J. M., Jakaitis, D. R., Lebrasseur, N. K., Jensen, M. D., Sreekumaran Nair, K., & Zabielski, P. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00584.2012 · Cited by 135
Zhu, M. J., Ma, Y., Long, N. M., Du, M., & Ford, S. P. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00309.2010 · Cited by 137
“p38 MAP kinase is known to be activated in OB conditions in mice (7, 27).”
BackgroundCrosstalk between mitochondrial (dys)function and mitochondrial abundance
Michel, S., Wanet, A., De Pauw, A., Rommelaere, G., Arnould, T., & Renard, P. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.23021 · Cited by 133
“…Weitzel and Alexander Iwen (2011) CREBa Cytochrome c, PGC-1a Franko et al. (2008), Vercauteren et al. (2006) YY1 COX genes Basu et al., (1997), Cunningham et al. (2007) C-MYCa MtDNA polymerase, NRF-1 target genes, PGC-1b Li et al. (2005), Morrish et al. (2003) MEF-2a PGC-1a, muscle-specific…”
Dysregulated metabolic pathways in age-related macular degeneration
Zhang, M., Jiang, N., Chu, Y., Postnikova, O. A., Varghese, R. S., Horvath, A., Cheema, A. K., & Golestaneh, N. (2020) · Scientific Reports · doi:10.1038/s41598-020-59244-4 · Cited by 139
Marciano, D. P., Chang, M. R., Corzo, C. A., Goswami, D., Lam, V. Q., Pascal, B. D., & Griffin, P. R. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.12.009 · Cited by 140
“Interestingly, genes related to the thermogenic program such as b2-AR, UCP-1, NOR-1, and PGC1(a/b) were increased in BAT in these mice (Bertin et al., 1990; Crunkhorn et al., 2007; Lau et al., 2008).”
BackgroundGolestaneh, N., Chu, Y., Cheng, S. K., Cao, H., Poliakov, E., & Berinstein, D. M. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1101-8 · Cited by 125
Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders
Morris, G., Puri, B. K., Walker, A. J., Maes, M., Carvalho, A. F., Bortolasci, C. C., Walder, K., & Berk, M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.025 · Cited by 113
Pavlovic, Z., & Bakovic, M. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14022529 · Cited by 116
“over-nutrition, obesity, and PGC-1 expression [47]”
BackgroundInfluentialMarwarha, G., Raza, S., Meiers, C., & Ghribi, O. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.015 · Cited by 107
RetractedWong, C. Y. J., Al‐Salami, H., & Dass, C. R. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13359 · Cited by 131
Elbein, S. C., Kern, P. A., Rasouli, N., Yao-Borengasser, A., Sharma, N. K., & Das, S. K. (2011) · Diabetes · doi:10.2337/db10-1270 · Cited by 107
Muscle insulin resistance: assault by lipids, cytokines and local macrophages
Kewalramani, G., Bilan, P. J., & Klip, A. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32833aabd9 · Cited by 106
Jin, W., Goldfine, A. B., Boes, T., Henry, R. R., Ciaraldi, T. P., Kim, E.-Y., Emecan, M., Fitzpatrick, C., Sen, A., Shah, A., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci41940 · Cited by 106
Self-citationCarson, J. A., Hardee, J. P., & VanderVeen, B. N. (2016) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.11.005 · Cited by 103
Prmt7 Deficiency Causes Reduced Skeletal Muscle Oxidative Metabolism and Age-Related Obesity
Jeong, H.-J., Lee, H.-J., Vuong, T. A., Choi, K.-S., Choi, D., Koo, S.-H., Cho, S. C., Cho, H., & Kang, J.-S. (2016) · Diabetes · doi:10.2337/db15-1500 · Cited by 101
p38 MAPK in Glucose Metabolism of Skeletal Muscle: Beneficial or Harmful?
Bengal, E., Aviram, S., & Hayek, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186480 · Cited by 114
“An additional aspect of the involvement p38 MAPK in insulin resistance is its suppression of PGC1α α and PGC1β expression that entails the accumulation of lipid metabolites [78].”
BackgroundMarineli, R. D. S., Moura, C. S., Moraes, É. A., Lenquiste, S. A., Lollo, P. C. B., Morato, P. N., Amaya‐Farfán, J., & Maróstica, M. R. (2014) · Nutrition · doi:10.1016/j.nut.2014.11.009 · Cited by 120
Huang, R., Garratt, E. S., Pan, H., Wu, Y., Davis, E. A., Barton, S. J., Burdge, G. C., Godfrey, K. M., Holbrook, J. D., & Lillycrop, K. A. (2015) · Epigenetics · doi:10.1080/15592294.2015.1080411 · Cited by 113
Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease
Collison, K. S., Maqbool, Z. M., Saleh, S. M., Inglis, A. L., Makhoul, N. J., Bakheet, R., Al‐Johi, M. A., Al‐Rabiah, R. K., Zaidi, M. Z., & Al-Mohanna, F. A. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800418-jlr200 · Cited by 104
PGC1α: Friend or Foe in Cancer?
Mastropasqua, F., Girolimetti, G., & Shoshan, M. C. (2018) · Genes · doi:10.3390/genes9010048 · Cited by 102
“The underlying mechanisms include promoter hypermethylation [25] that can be due to effects of saturated fatty acids [18,26], and of inflammatory cytokines such as tumor necrosis factor-like inducer of apoptosis (TWEAK) of the tumor necrosis factor (TNF) family [27].”
BackgroundGünther, T. (2010) · Magnesium Research · doi:10.1684/mrh.2009.0195 · Cited by 88
Turdi, S., Ge, W., Hu, N., Bradley, K. M., Wang, X., & Ren, J. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.12.007 · Cited by 88
Exercise and the Treatment of Diabetes and Obesity
O’Gorman, D. J., & Krook, A. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.07.006 · Cited by 100
Supruniuk, E., Mikłosz, A., & Chabowski, A. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00923 · Cited by 86
“Consistent with this notion, the reduced PGC-1α transcription has been observed in skeletal muscle (Crunkhorn et al., 2007) and adipose cells (Semple et al.”
BackgroundInfluentialMartins, A. R., Crisma, A. R., Masi, L. N., do Amaral, C. L., Marzuca-Nassr, G. N., Bomfim, L. H. M., Teodoro, B. G., Queiroz, A. L., Serdan, T. D. A., Torres, R. P., et al. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.11.012 · Cited by 95
Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy
Morató, L., Galino, J., Ruiz, M., Calingasan, N. Y., Starkov, A. A., Dumont, M., Naudí, A., Martínez, J. J., Aubourg, P., Portero-Otín, M., et al. (2013) · Brain · doi:10.1093/brain/awt143 · Cited by 82
“This may suggest that the excess of C26:0 could negatively regulate the expression of PGC-1 , perhaps in a similar manner than a high fat diet or saturated fatty acid treat- ment does (Mootha et al., 2003; Richardson et al., 2005 Crunkhorn et al., 2007).”
BackgroundSoumura, M., Kume, S., Isshiki, K., Takeda, N., Araki, S., Tanaka, Y., Sugimoto, T., Chin‒Kanasaki, M., Nishio, Y., Haneda, M., et al. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.012 · Cited by 88
Role of Pyruvate Dehydrogenase Kinase 4 in Regulation of Blood Glucose Levels
Jeoung, N. H., & Harris, R. A. (2010) · Korean Diabetes Journal · doi:10.4093/kdj.2010.34.5.274 · Cited by 78
Genetic determinants and molecular pathways in the pathogenesis of Type 2 diabetes
Jin, W., & Patti, M.-E. (2009) · Clinical Science · doi:10.1042/cs20080090 · Cited by 78
Self-citationChoi, J., Ravipati, A., Nimmagadda, V. K. C., Schubert, M., Castellani, R. J., & Russell, J. W. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.09.005 · Cited by 78
“Palmitate was conjugated to BSA as described (Crunkhorn et al., 2007).”
MethodRole of stearoyl-CoA desaturases in obesity and the metabolic syndrome
Popeijus, H. E., Saris, W. H. M., & Mensink, R. P. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.55 · Cited by 83
A comprehensive review on high -fat diet-induced diabetes mellitus: an epigenetic view
Prasad, M., Rajagopal, P., Devarajan, N., Veeraraghavan, V. P., Palanisamy, C. P., Cui, B., Patil, S., & Jayaraman, S. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109037 · Cited by 90
Ruddock, M. W., Stein, A., Landaker, E., Park, J., Cooksey, R. C., McClain, D., & Patti, M.-E. (2008) · Journal of Biochemistry · doi:10.1093/jb/mvn105 · Cited by 75
Self-citationBaicalin against obesity and insulin resistance through activation of AKT/AS160/GLUT4 pathway
Fang, P., Yu, M., Zhang, L., Wan, D., Shi, M., Zhu, Y. N., Ping, B., & Zhang, Z. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.03.027 · Cited by 74
Henagan, T. M., Lenard, N. R., Gettys, T. W., & Stewart, L. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089365 · Cited by 71
“Importantly, PGC1a is downregulated in skeletal muscle by HFD and decreased in skeletal muscle of type 2 diabetic individuals [6,13].”
Tang, R., Harasymowicz, N. S., Wu, C., Collins, K. H., Choi, Y., Oswald, S. J., & Guilak, F. (2020) · Science Advances · doi:10.1126/sciadv.aaz7492 · Cited by 75
Muscle mitohormesis promotes cellular survival via serine/glycine pathway flux
Ost, M., Keipert, S., van Schothorst, E. M., Donner, V., van der Stelt, I., Kipp, A. P., Petzke, K., Jove, M., Pamplona, R., Portero‐Otin, M., et al. (2015) · The FASEB Journal · doi:10.1096/fj.14-261503 · Cited by 69
Pérez, S., Rius‐Pérez, S., Finamor, I., Martí‐Andrés, P., Priéto, I., García-Gómez, R., Monsalve, M., & Sastre, J. (2018) · The Journal of Pathology · doi:10.1002/path.5166 · Cited by 74
“We may hypothesize that either hypermethylation of the Ppargc1a promoter [39] or downregulation by increased fatty acid levels, particularly palmitate, might be involved in the decrease in pancreatic PGC-1α levels in obese animals [40].”
BackgroundBarth, A. S., Kumordzie, A., Frangakis, C., Margulies, K. B., Cappola, T. P., & Tomaselli, G. F. (2011) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.110.957571 · Cited by 74
Contreras, G. A., Raphael, W., Mattmiller, S. A., Gandy, J. C., & Sordillo, L. M. (2012) · Journal of Dairy Science · doi:10.3168/jds.2012-5382 · Cited by 79
MAPK phosphatase-1 facilitates the loss of oxidative myofibers associated with obesity in mice
Roth, R. J., Le, A. M., Zhang, L., Kahn, M., Samuel, V. T., Shulman, G. I., & Bennett, A. M. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39054 · Cited by 65
PPARs and the orchestration of metabolic fuel selection
Sugden, M. C., Zariwala, M. G., & Holness, M. J. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.03.014 · Cited by 64
The impact of a high-fat diet in mice is dependent on duration and age, and differs between muscles
Messa, G. A. M., Piasecki, M., Hurst, J., Hill, C., Tallis, J., & Degens, H. (2020) · Journal of Experimental Biology · doi:10.1242/jeb.217117 · Cited by 63
“Given the positive relationship between muscle fatigue resistance and oxidative capacity in motor units and single muscle fibers (Degens and Veerkamp, 1994), part of the lower fatigue resistance in skeletal muscle of obese people may be due to a reduced oxidative capacity (Crunkhorn et al., 2007; Koves et al., 2005; S…”
BackgroundKien, C. L., Everingham, K. I., Stevens, R. D., Fukagawa, N. K., & Muoio, D. M. (2011) · Obesity · doi:10.1038/oby.2010.135 · Cited by 63
Hwang, B., Jeoung, N. H., & Harris, R. A. (2009) · Biochemical Journal · doi:10.1042/bj20090390 · Cited by 63
“These include studies that have shown PGC-1α is reduced in the skeletal muscle of type 2 diabetic patients [27], reduced in the skeletal muscle of mice fed a HSF diet for 8 weeks [ 28 ], reduced in human fatty liver relative to normal human liver [29], and reduced in the liver of mice fed a HSF diet relative to a high…”
BackgroundRyu, M. J., Kim, S. J., Kim, Y. K., Choi, M. J., Tadi, S., Lee, M. H., Lee, S. E., Chung, H. K., Jung, S. B., Kim, H. J., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003356 · Cited by 68
“It is reported that adipose OXPHOS capacity is controlled by both genetic and diet-induced obesity [10,44,45], which potentially contribute to adipose tissue dysfunction and exacerbation of insulin resistance.”
BackgroundEffect of betaine on hepatic insulin resistance through FOXO1-induced NLRP3 inflammasome
Kim, D. H., Kim, S. M., Lee, B., Lee, E. K., Chung, K. W., Moon, K. M., An, H. J., Kim, K. M., Yu, B. P., & Chung, H. Y. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.04.014 · Cited by 67
Hager, L., Li, L., Pun, H., Liu, L., Hossain, M. A., Maguire, G. F., Naples, M., Baker, C., Magomedova, L., Tam, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.340919 · Cited by 61
“Oxidative stress pathways can in turn activate the kinases JNK and NFKB to upregulate cytokines, causing dysfunctional fatty acid oxidation, adipokine secretion, and glucose homeostasis [77-79].”
BackgroundCARD9 knockout ameliorates myocardial dysfunction associated with high fat diet-induced obesity
Cao, L., Qin, X., Peterson, M. R., Haller, S. E., Wilson, K. A., Hu, N., Lin, X., Nair, S., Ren, J. T., & He, G. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.02.014 · Cited by 62
Espinoza, D. O., Boros, L. G., Crunkhorn, S., Gami, H., & Patti, M.-E. (2010) · The FASEB Journal · doi:10.1096/fj.09-133728 · Cited by 59
“Moreover, PGC-1 expression and function are reduced in settings of lipid excess, including both genetic and dietary obesity in rodents (28, 29) and after acute high-fat feeding (30) or lipid infusion in healthy humans (31).”
BackgroundSelf-citationDifferent impacts of saturated and unsaturated free fatty acids on COX-2 expression in C2C12myotubes
Kadotani, A., Tsuchiya, Y., Hatakeyama, H., Katagiri, H., & Kanzaki, M. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00293.2009 · Cited by 58
“On the other hand, saturated FFAs also reportedly activate members of the MAPK family, including ERK1/2, p38, and JNK (10, 11, 51), although their possible involvement in proinflammatory responses in skeletal muscle cells is poorly understood.”
BackgroundInfluentialEpigenetic changes in diabetes
Al-Haddad, R., Karnib, N., Assaad, R. A., Bilen, Y., Emmanuel, N., Ghanem, A., Younes, J., Zibara, V., Stephan, J. S., & Sleiman, S. F. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.046 · Cited by 58
Sarg, N. H., Zaher, D. M., Jayab, N. N. A., Mostafa, S. H., Ismail, H. H., & Omar, H. A. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116307 · Cited by 70
Novel Intriguing Strategies Attenuating to Sarcopenia
Sakuma, K., & Yamaguchi, A. (2012) · Journal of Aging Research · doi:10.1155/2012/251217 · Cited by 69
“It was found that a high-fat diet or fatty acid treatment caused a reduction in the expression of PGC1α and other mitochondrial genes in skeletal muscle [128], which may be a mechanism through which excess caloric intake impairs skeletal muscle function.”
BackgroundWang, S., Kamat, A., Pérgola, P. E., Swamy, A., Tio, F. O., & Cusi, K. J. (2011) · Metabolism · doi:10.1016/j.metabol.2010.12.001 · Cited by 55
“This is consistent with studies in rodents [34] and humans [35] in which an experimental increase in plasma FFA decreases skeletal muscle PGC-1α gene expression.”
BackgroundResultInteraction between maternal obesity and post-natal over-nutrition on skeletal muscle metabolism
Simar, D., Chen, H., Lambert, K., Mercier, J. G., & Morris, M. J. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.11.007 · Cited by 60
“PGC-1a is a master regulator of mitochondrial biogenesis [18] and is down-regulated in response to adverse metabolic environments, such as HFD-consumption, due to fatty acid accumulation [10].”
BackgroundBucher, M., Montaniel, K. R. C., Myatt, L., Weintraub, S. T., Tavori, H., & Maloyan, A. (2020) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174420001026 · Cited by 56
Metadata
- Authors
- Crunkhorn, S., Dearie, F., Mantzoros, C., Gami, H., da Silva, W. S., Espinoza, D., Faucette, R., Barry, K., Bianco, A. C., & Patti, M. E.
- Affiliations
- Joslin Diabetes Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Patti, Mary Elizabeth
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-05
- Volume
- 282
- Issue
- 21
- Pages
- 15439-15450
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2094879159
- Cited by
- 236
- References
- 75
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 2 · 2022: 6 · 2021: 8 · 2020: 11 · 2019: 7 · 2018: 15 · 2017: 10 · 2016: 9 · 2015: 11 · 2014: 20 · 2013: 15 · 2012: 26
- FWCI
- 8.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4903 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK36836, DK 65055, DK-062948, R01DK065055, R01DK060837, DK060837, R01DK062948, P30DK036836)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- PGC-1α, PGC-1β, obesity, saturated fatty acids, palmitate, p38 MAPK, mitochondrial gene expression, skeletal muscle, high-fat diet, histone deacetylase, oxidative phosphorylation, TCA cycle, oxygen consumption, A/J mice, transcriptional regulation
- MeSH terms
- Adipose Tissue, Amino Acids, Animals, Cell Line, Citric Acid Cycle, Dietary Fats, Enzyme Activation, Gene Expression Regulation, Glucosamine, Glucose, Histone Deacetylases, Hypoglycemic Agents, Insulin, Mice, Obese, Obesity, Oxidative Phosphorylation, RNA, Messenger, Sweetening Agents, Time Factors, Transcription Factors, Transcription, Genetic, Muscle Fibers, Skeletal, Palmitic Acid, MAP Kinase Signaling System, Mitochondrial Proteins, p38 Mitogen-Activated Protein Kinases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.